Cirata earnings date
Cirata (WD4) Q2 2026 Earnings Report
DE:WD4 Q2 2026 EPS Results
- Actual EPS
- EUR 0.04
- Consensus EPS
- -EUR 0.03
- Beat/Miss
- Beat by +EUR 0.06
- One Year Ago EPS
- -EUR 0.03
DE:WD4 Q2 2026 Revenue Results
- Actual Revenue
- EUR 852.85K
- Expected Revenue
- EUR 907.25K
- Beat/Miss
- Missed by -EUR 54.40K
- YoY Revenue Growth
- -71.24%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 09/16/2026
- Time
- Before Open
- Conference Call
- Wednesday, September 16, 2026
Cirata's next earnings date is estimated for April 7, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
The call was predominantly positive, supported by an oversubscribed $7.2 million fundraise, a 40% pipeline increase to GBP 21 million ACV, full go-to-market staffing, the first live Symphony deployment, IBM OEM validation, disciplined overheads, and reaffirmed FY 2026 cash flow breakeven guidance. The main setbacks were the lack of new-logo wins in Q2, GBP 2.1 million of net cash consumption, and the acknowledged need to improve product messaging.
Management reaffirmed its outlook to target cash flow breakeven for FY 2026, with total overheads at GBP 3.2 million in Q2 consistent with the FY 2026 annualized range between GBP 12 million and GBP 13 million, representing a reduction of over 70% from the peak; the second-half goal is to execute with focus, convert the pipeline into new customer wins, and demonstrate that a fully resourced go-to-market organization can deliver new customer acquisition and scale building on the FY 2025 growth trajectory, with new logo conversion expected to show up as the year progresses.
- Oversubscribed $7.2 Million FundraiseFollowing shareholder approval, the placing, subscription, and retail offer became unconditional and raised gross proceeds of $7.2 million. The round was oversubscribed, with admission of the new shares expected on 28 July 2026. Management said the proceeds strengthen the balance sheet and provide runway to invest with discipline in go-to-market capability, new-logo acquisition, pipeline conversion, and product scale.
- Major Reduction in Expense RateThe company stated that its expense rate has been reduced by over 70% from the peak. Since the company came together three years ago, it has raised circa GBP 35 million net of fees.
- Closing ACV Increased 8.2% SequentiallyClosing ACV increased from GBP 4.9 million at the start of the quarter to GBP 5.3 million at the end of Q2. Net new ACV was stated as GBP 0.4 million in the prepared remarks and GBP 410,000 in the Q&A, driven entirely by renewals and expansion within the existing customer base.
- Pipeline Grew 40% to GBP 21 Million ACVThe pipeline grew by 40% between January and April, reaching GBP 21 million of annual contract value. Management said both pipeline volume and quality continued to strengthen after April, partly because the go-to-market team became fully resourced following final hires in June and July.
- Go-to-Market Team Fully ResourcedThe company completed final go-to-market hires in the U.S. and U.K. in June and July. Management said the team is focused on Global 2000 accounts, including new logos and expansion within the existing customer base, and is increasingly embedded in key territories and strategic accounts.
- Significant Data Migration Track RecordCirata stated that it has moved circa 300 petabytes of data for customers, positioning the company to help prospective customers with petabyte-scale data project delivery.
- Cirata Symphony Reached First Live DeploymentCirata Symphony moved from beta and proof of concept into real-world deployment, with a major U.K. retailer running live iceberg-to-iceberg replication after a successful beta trial.
- Additional Symphony Customer ProgressCirata Symphony is progressing through beta testing with a large, described in the Q&A as a top-three, U.S. bank. The company also moved to a proof of concept with a new prospective customer in the U.S.
- IBM OEM Agreement Validated SymphonyOn 16 June 2026, Cirata Symphony became deliverable under the IBM agreement as Cirata Symphony for IBM Big Replicate. Management described this as a validation milestone that places IBM's name and distribution behind the product and opens a significantly wider route to market. Approximately 40% of the pipeline is co-sourced with IBM.
- Strategic Positioning in Complex Data Use CasesManagement said Cirata addresses some of the hardest and most complex large-scale data use cases for Global 2000 companies. Cirata Symphony was described as an open-standards platform designed to help customers manage infrastructure complexity and regain control of their data.
- Cash Balance and Receivables PositionAs of 30 June 2026, unaudited cash was GBP 2.6 million. Short-term receivables brought the cash-plus-receivables position to GBP 2.8 million, while the recent fundraise provided gross proceeds of $7.2 million.
- First Positive Cash Flow Quarter AchievedThe company recorded its first quarter of positive cash flow in Q1 FY 2026.
- Overheads Within Annualized Target RangeQ2 total overheads were GBP 3.2 million, consistent with the FY 2026 annualized range of GBP 12 million to GBP 13 million. Management reiterated that this represents a reduction of over 70% from the peak.
- FY 2026 Cash Flow Breakeven Target ReaffirmedCirata reaffirmed the outlook shared on 14 January 2026 and continued to target cash flow breakeven for FY 2026.
- Turnaround Milestones DeliveredOver the last year, the company said it divested a legacy business, built and launched the Cirata Symphony platform, deployed it with a major retailer, and delivered its first cash-positive quarter in Q1.
DE:WD4 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Apr 07, 2027 | 2026 (Q4) | ―- | 0.04 | ― | ― |
| Sep 16, 2026 | 2026 (Q2) | -0.030.04 | -0.03 | 233.33% (+0.06) | |
| Mar 31, 2026 | 2025 (Q4) | ―0.04 | -0.03 | 225.00% (+0.08) | |
| Sep 03, 2025 | 2025 (Q2) | ―-0.03 | -0.06 | 57.14% (+0.04) | |
| Mar 31, 2025 | 2024 (Q4) | ―-0.03 | -0.12 | 71.13% (+0.08) | |
| Sep 04, 2024 | 2024 (Q2) | ―-0.06 | -0.2 | 68.18% (+0.14) | |
| Apr 04, 2024 | 2023 (Q4) | ―-0.12 | -0.38 | 69.01% (+0.26) | |
| Sep 11, 2023 | 2023 (Q2) | ―-0.20 | -0.23 | 12.00% (+0.03) | |
| Jun 29, 2023 | 2022 (Q4) | ―-0.38 | -0.26 | -46.95% (-0.12) | |
| Sep 06, 2022 | 2022 (Q2) | ―-0.23 | 0.28 | -180.65% (-0.51) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

